319 related articles for article (PubMed ID: 28602890)
1. Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.
Gaziev J; Marziali S; Paciaroni K; Isgrò A; Di Giuliano F; Rossi G; Marziali M; De Angelis G; Alfieri C; Ribersani M; Andreani M; Palmieri MG; Placidi F; Romigi A; Izzi F; Floris R; Mercuri NB
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1531-1540. PubMed ID: 28602890
[TBL] [Abstract][Full Text] [Related]
2. Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells.
Kharbanda S; Smith AR; Hutchinson SK; McKenna DH; Ball JB; Lamb LS; Agarwal R; Weinberg KI; Wagner JE
Biol Blood Marrow Transplant; 2014 Apr; 20(4):581-6. PubMed ID: 24370862
[TBL] [Abstract][Full Text] [Related]
3. Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell Transplantation in Children and Adolescents.
Dandoy CE; Linscott LL; Davies SM; Leach JL; Myers KC; El-Bietar J; Chima RS; Pate A; Nelson A; Wallace G; Wong HR; Jodele S
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2028-32. PubMed ID: 26226408
[TBL] [Abstract][Full Text] [Related]
4. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors.
Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217
[TBL] [Abstract][Full Text] [Related]
5. Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial.
Abraham A; Cluster A; Jacobsohn D; Delgado D; Hulbert ML; Kukadiya D; Murray L; Shenoy S
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1587-1592. PubMed ID: 28578010
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
[TBL] [Abstract][Full Text] [Related]
7. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
8. Severe hypertension is an independent risk factor for posterior reversible encephalopathy syndrome post-hematopoietic cell transplantation in children with thalassemia major.
Li XY; Huang K; Zhou DH; Li Y; Xu HG; Weng WJ; Xu LH; Fang JP
Clin Transplant; 2019 Jan; 33(1):e13459. PubMed ID: 30506735
[TBL] [Abstract][Full Text] [Related]
9. Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa.
Khandelwal P; Yeh RF; Yu L; Lane A; Dandoy CE; El-Bietar J; Davies SM; Grimley MS
Transplantation; 2021 Apr; 105(4):891-896. PubMed ID: 32467478
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin inhibitor-free strategies for prophylaxis and treatment of GVHD in children with posterior reversible encephalopathy syndrome after stem cell transplantation.
Shkalim-Zemer V; Konen O; Levinsky Y; Michaeli O; Yahel A; Krauss A; Yaniv I; Stein J
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28417553
[TBL] [Abstract][Full Text] [Related]
11. Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South India.
Swaminathan VV; Uppuluri R; Patel S; Ravichandran N; Ramanan KM; Vaidhyanathan L; Ramakrishnan B; Jayakumar I; Raj R
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1326-1331. PubMed ID: 32200123
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation.
Hammerstrom AE; Howell J; Gulbis A; Rondon G; Champlin RE; Popat U
Am J Hematol; 2013 Apr; 88(4):301-5. PubMed ID: 23460378
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience.
Kogel F; Hakimeh D; Sodani P; Lang P; Kühl JS; Hundsdoerfer P; Künkele A; Eggert A; Oevermann L; Schulte JH
Pediatr Transplant; 2021 Mar; 25(2):e13892. PubMed ID: 33098344
[TBL] [Abstract][Full Text] [Related]
14. HLA-matched sibling stem cell transplantation in children with β-thalassemia with anti-thymocyte globulin as part of the preparative regimen: the Greek experience.
Goussetis E; Peristeri I; Kitra V; Vessalas G; Paisiou A; Theodosaki M; Petrakou E; Dimopoulou MN; Graphakos S
Bone Marrow Transplant; 2012 Aug; 47(8):1061-6. PubMed ID: 22080966
[TBL] [Abstract][Full Text] [Related]
15. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.
Locatelli F; Rocha V; Reed W; Bernaudin F; Ertem M; Grafakos S; Brichard B; Li X; Nagler A; Giorgiani G; Haut PR; Brochstein JA; Nugent DJ; Blatt J; Woodard P; Kurtzberg J; Rubin CM; Miniero R; Lutz P; Raja T; Roberts I; Will AM; Yaniv I; Vermylen C; Tannoia N; Garnier F; Ionescu I; Walters MC; Lubin BH; Gluckman E;
Blood; 2003 Mar; 101(6):2137-43. PubMed ID: 12424197
[TBL] [Abstract][Full Text] [Related]
16. [Retrospective analysis of posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation].
Aisa Y; Mori T; Shimizu T; Tsukada Y; Kato J; Suzuki S; Suzuki N; Ikeda Y; Okamoto S
Rinsho Ketsueki; 2009 Jan; 50(1):9-15. PubMed ID: 19225223
[TBL] [Abstract][Full Text] [Related]
17. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
[TBL] [Abstract][Full Text] [Related]
18. Posterior Reversible Encephalopathy Syndrome in Pediatric Hematopoietic Stem Cell Transplantation with Beta Major Thalassemia: The Association between the PRES Occurrence and Class of Beta Major Thalassemia.
Jafari L; Behfar M; Tabatabaie S; Karamlou Y; Kashani H; Radmard AR; Mohseni R; Naji P; Ghanbari F; Ashkevari P; Fakhr H; Mohammadi S; Hamidieh AA
Clin Transplant; 2024 Jan; 38(1):e15164. PubMed ID: 37847603
[TBL] [Abstract][Full Text] [Related]
19. Clinical Management of Posterior Reversible Encephalopathy Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Series and Review of the Literature.
Schmidt V; Prell T; Treschl A; Klink A; Hochhaus A; Sayer HG
Acta Haematol; 2016; 135(1):1-10. PubMed ID: 26159650
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of matched sibling donor bone marrow transplantation in children using single-agent calcineurin inhibitors as prophylaxis for graft versus host disease.
Elgarten CW; Arnold DE; Bunin NJ; Seif AE
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28748621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
